Ginkgo biloba extract EGb 761 has anti-inflammatory properties and ameliorates colitis in mice by driving effector T cell apoptosis
Open Access
- 20 June 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Carcinogenesis: Integrative Cancer Research
- Vol. 29 (9), 1799-1806
- https://doi.org/10.1093/carcin/bgn143
Abstract
Ulcerative colitis is a dynamic, chronic inflammatory condition of the colon associated with an increased colon cancer risk. Ginkgo biloba is a putative antioxidant and has been used for thousands of years to treat a variety of ailments. The aim of this study was to test whether the standardized G.biloba extract, EGb 761, is an antioxidant that can be used to prevent and treat colitis in mice. Here, we show that EGb 761 suppresses the activation of macrophages and can be used to both prevent and treat mouse colitis. Markers of inflammation (iNOS, Cox-2 and tumor necrosis factor-α) and inflammatory stress (p53 and p53-phospho-serine 15) are also downregulated by EGb 761. Furthermore, we show that EGb 761 reduces the numbers of CD4+/CD25−/Foxp3− effector T cells in the colon. Interestingly, EGb 761 drives CD4+ effector T cell apoptosis in vitro and in vivo , providing a mechanistic explanation to the reduction in numbers of this cell type in the colon. This current study is in agreement with previous studies supporting a use of EGb 761 as a complementary and alternative strategy to abate colitis and associated colon cancer.Keywords
This publication has 43 references indexed in Scilit:
- Treatment of inflammatory bowel disease: A review of medical therapyWorld Journal of Gastroenterology, 2008
- Effects ofGinkgo bilobaExtract on Inflammatory Mediators (SOD, MDA, TNF-, NF-Bp65, IL-6) in TNBS-Induced Colitis in RatsMediators of Inflammation, 2006
- Current Limitations of IBD TreatmentAnnals of the New York Academy of Sciences, 2006
- Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitisNature Clinical Practice Gastroenterology & Hepatology, 2006
- Ginkgo biloba attenuates mucosal damage in a rat model of ulcerative colitisPharmacological Research, 2006
- Preventive Effect of Ginkgo biloba Extract (GBB) on the Lipopolysaccharide-Induced Expressions of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 via Suppression of Nuclear Factor-.KAPPA.B in RAW 264.7 CellsBiological & Pharmaceutical Bulletin, 2006
- Identifying and defusing weapons of mass inflammation in carcinogenesisBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2006
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cellsOral Oncology, 2005
- Resolution of chronic inflammation by therapeutic induction of apoptosisTrends in Pharmacological Sciences, 1996